SPHK1 and nonpapillary renal cell carcinoma: SFMBT1 activity is essential for growth of ccRCC xenografts, and this effect appears to be at least partly mediated by its target gene SPHK1 as genetic knockdown or pharmacological inhibition of SPHK1 inhibits ccRCC xenograft growth [20].